NCT04637529View on ClinicalTrials.gov

Efficacy and Safety of S (+) - Ibuprofen in Osteoarthritis Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

176

Participants

Timeline

Start Date

August 5, 2022

Primary Completion Date

June 30, 2023

Study Completion Date

June 30, 2023

Conditions
Osteoarthritis
Interventions
DRUG

S (+) - Ibuprofen

S (+) - Ibuprofen + placebo of Ibuvix®

DRUG

Ibuvix® - ibuprofen

Ibuvix® + placebo of S(+) - Ibuprofen

Trial Locations (1)

04753-001

Apsen Farmacêutica S.A., São Paulo

Sponsors
All Listed Sponsors
lead

Apsen Farmaceutica S.A.

INDUSTRY